Optimized by engineering and artificial intelligence
Fluidda is the world leader in the field of Functional Respiratory Imaging. This technique combines HRCT scans and Computational Fluid Dynamics technology, which offers vast improvements by making clinical trials shorter, faster and thus, more cost effective.
FRI also helps patients and healthcare providers in offering a unique entry point in personalized medicine, by optimizing diagnosis, monitoring disease progression and the effects of therapy. Fluidda is both a CRO services company and a partner of healthcare professionals by offering worldwide evidence for better respiratory treatment.
Our mission is to optimize treatment pathways, reduce healthcare costs and to limit the go-to-market time of respiratory drugs, pulmonology medical devices and therapies.
is all about understanding lung pathology and physiology
Dr. Jan De Backer
BREATHE THE AIR!
With one person dying every minute from a respiratory condition, patients with pulmonary diseases deserve better, faster and less costly treatments. At Fluidda, we are leading the way in a world where the quality of air is under stress.
Our aim is to optimize treatment pathways, reduce healthcare costs, bring therapies to the market faster and move toward value-based healthcare. Our FRI technology will help patients worldwide to breathe the air!
Fluidda’s 1st Research And Findings Magazine
Discover all the latest research and FRI applications by entering your e-mail address below and we will send you this Magazine for free. The following topics are covered in the first edition of our magazine:
- FRI as a solution for unmet patient care
- Recent data on COVID-19 and COPD
- Make clinical trials smaller, faster, and more cost-effective
Send download link to:
Are you a Healthcare company?
Fluidda can speed up your respiratory drug development or medical device development and derisk clinical trials.
Recent News >
Fluidda helps Firefighters
Californian firefighters are exposed to repeated, intense wildfire smoke, and the long term effects are still unknown. FiGHT is a non-profit charity campaign aiming at screening firefighters and first responders for lung diseases that might be present but are not yet reflected in standard of care (spirometry) or symptoms.
Fluidda’s Functional Respiratory Imaging technology combined with artificial intelligence allows patient-specific treatment to be assigned. Discover how Fluidda supports firefighters on https://www.jointhefight.info/